FLGR-242 – The Muscle Building Compound That’s Changing Everything Pt. 2 | Peptide of the Week Pod
Podcast:Peptide of The Week Published On: Wed Nov 04 2026 Description: Follow us on social media:JD's Socials: https://hoo.be/jddenhamofficialWill's Socials: https://hoo.be/williamthaasPeptide Of The Week Socials: https://hoo.be/peptideoftheweekpodcastJoin The Community: https://www.skool.com/peptideresearchinstitute/aboutSubscribe to our Newsletter: https://potwnewsletter.beehiiv.com/Warrior Coaching: https://www.warrior-makerscoaching.comPeptide Of The Week Website: https://peptideoftheweekpod.comMedical Disclaimer: We are not doctors. The content in this video is for educational and informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Any compounds discussed may be intended for research purposes only. Use at your own risk.Part two with Michael Farber goes deep on FLGR-242, the long acting myostatin inhibitor he invented that is helping people gain 10 to 12 pounds of lean muscle in three to four months, without anabolics, without side effects, and regardless of genetics. This is one of the most important muscle building conversations we have ever had on this podcast.🔬 Topics Covered:• Why Farber invented FLGR-242 after losing 2+ years of muscle during COVID• What myostatin actually is and why it is your body's brake on muscle growth and fat burning• Belgian blue cows, super mice, and real world examples of myostatin mutations• Why naturally gifted athletes often have partial myostatin mutations and do not even know it• How FLGR-242 levels the playing field for people not born with athletic genetics• Expected results: 10 to 12 pounds of lean muscle in 3 to 4 months at 5mg per week• Why going above 10mg per week produces virtually no additional gains• Farber personally went to 20mg per week and confirmed no negative health effects above 10mg• How FLGR-242 was designed to bind ONLY myostatin and why that makes it so safe• Why Follistatin-344 causes random growth and must be injected locally while FLGR-242 freely circulates• Brian Johnson's myostatin experiment in Honduras: 2% gain in a year at $50,000 per try• FLGR-242 vs circular DNA myostatin inhibitors: not even close• Apelin-13: the ergogenic compound that optimizes fat burning and cardiovascular output simultaneously• Long acting Thymosin Alpha-1 and Thymosin Beta coming soon• Bioline: the new appetite and metabolism compound coming down the pipeline• The albumin binder platform and why it is changing how every compound performsChapters:00:00 – Intro00:09 – Welcome Back & Will's Mom Moving to Town01:24 – Appreciating Your Parents While You Have Them03:29 – Round Two With Michael Farber: Why He Created FLGR-24206:27 – Myostatin Inhibition Beyond Muscle: Obesity & Fetal Growth10:02 – Leveling the Playing Field for Natural Athletes12:21 – Real-World Results: 10–12 Pounds of Lean Muscle in 4 Months14:44 – Dosing: Why More Than 10 mg a Week Doesn't Help19:23 – How FLGR-242 Differs From Follistatin 34424:06 – Safety Record & Gene Therapy Alternatives27:55 – What's Next: Apelin, Long-Acting Thymosin & Obesity Compounds30:16 – The Albumin Binder Discovery: MC4R & Amylin Compounds34:34 – Cancer Drug Trojan Horse Idea36:40 – Upcoming Launches: Appetite Control & Long-Acting Thymosin Alpha-138:44 – Outro